George Elston | Chief Financial Officer |
Dr. Jay Duker | President, and Chief Executive Officer |
Tyler Van Buren | Cowen |
Yatin Suneja | Guggenheim |
Jennifer Kim | Cantor Fitzgerald |
Colleen Kusy | Baird |
Daniel Catalin | Chardan |
Sean Kim | Jones Trading |
I-Eh Jen | Laidlaw & Co |
Chaitanya Gollakota | H.C. Wainwright |
Good morning. My name is [indiscernible] and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Second Quarter 2023 Financial Results and Recent Corporate Development Conference Call. There will be a question and answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the Company's request.